Annual Cash & Cash Equivalents
$2.91 M
+$2.78 M+2173.61%
31 December 2023
Summary:
Carmell Therapeutics Corporatio annual cash & cash equivalents is currently $2.91 million, with the most recent change of +$2.78 million (+2173.61%) on 31 December 2023. CTCX annual cash & cash equivalents is now at all-time high.CTCX Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Cash And Cash Equivalents
$1.14 M
-$1.06 M-48.26%
30 September 2024
Summary:
Carmell Therapeutics Corporatio quarterly cash and cash equivalents is currently $1.14 million, with the most recent change of -$1.06 million (-48.26%) on 30 September 2024. Over the past year, it has dropped by -$6.83 million (-85.73%). CTCX quarterly cash and cash equivalents is now -85.73% below its all-time high of $7.97 million, reached on 30 September 2023.CTCX Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CTCX Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +2173.6% | -85.7% |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
CTCX Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | >+9999.0% | -85.7% | >+9999.0% |
| 5 y | 5 years | at high | >+9999.0% | -85.7% | >+9999.0% |
| alltime | all time | at high | >+9999.0% | -85.7% | >+9999.0% |
Carmell Therapeutics Corporatio Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $1.14 M(-48.3%) |
| June 2024 | - | $2.20 M(+146.4%) |
| Mar 2024 | - | $892.20 K(-69.4%) |
| Dec 2023 | $2.91 M | $2.91 M(-63.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2023 | - | $7.97 M(>+9900.0%) |
| June 2023 | - | $10.20 K(-92.0%) |
| Dec 2022 | $128.10 K(+933.1%) | $128.10 K |
| Dec 2021 | $12.40 K | - |
FAQ
- What is Carmell Therapeutics Corporatio annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Carmell Therapeutics Corporatio?
- What is Carmell Therapeutics Corporatio annual cash & cash equivalents year-on-year change?
- What is Carmell Therapeutics Corporatio quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Carmell Therapeutics Corporatio?
- What is Carmell Therapeutics Corporatio quarterly cash and cash equivalents year-on-year change?
What is Carmell Therapeutics Corporatio annual cash & cash equivalents?
The current annual cash & cash equivalents of CTCX is $2.91 M
What is the all time high annual cash & cash equivalents for Carmell Therapeutics Corporatio?
Carmell Therapeutics Corporatio all-time high annual cash & cash equivalents is $2.91 M
What is Carmell Therapeutics Corporatio annual cash & cash equivalents year-on-year change?
Over the past year, CTCX annual cash & cash equivalents has changed by +$2.78 M (+2173.61%)
What is Carmell Therapeutics Corporatio quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of CTCX is $1.14 M
What is the all time high quarterly cash and cash equivalents for Carmell Therapeutics Corporatio?
Carmell Therapeutics Corporatio all-time high quarterly cash and cash equivalents is $7.97 M
What is Carmell Therapeutics Corporatio quarterly cash and cash equivalents year-on-year change?
Over the past year, CTCX quarterly cash and cash equivalents has changed by -$6.83 M (-85.73%)